Donate

Quantitative Imaging Workshop

Quantitative Imaging Workshop XVIII: Optimizing Thoracic Imaging to Detect and Manage Early Lung Cancer/COPD

Quantitative Imaging Workshop XVIII: Optimizing Thoracic Imaging to Detect and Manage Early Lung Cancer/COPD

November 4-5, 2021 | Virtual

Register now

Agenda

Quantitative Imaging Workshop is a high-impact multi-disciplinary forum for the advancement of quantitative low-dose computerized tomography (LDCT) imaging biomarkers for detection and management of early thoracic disease—lung cancer, COPD and cardiovascular disease—three of the top four leading causes of death in the U.S.

Since 2004, the Prevent Cancer Foundation® has convened a series of annual Workshops to exchange ideas on exciting new biomedical opportunities that this transformational technology enables as well as information on the quality and consistency of policy and advocacy for responsible lung cancer, COPD and cardiovascular screening.

To demonstrate our commitment to making this workshop as widely available as possible and through the generosity of our sponsors, the 2021 Quantitative Imaging Workshop is free to anyone who would like to register.

Goals and History of the Workshop

Summary of QIW XVII (2020)

Since 2004, the Quantitative Imaging Workshop focuses on the advancement of quantitative low-dose computerized tomography (LDCT) imaging biomarkers for detection and management of early thoracic disease—lung cancer, COPD and cardiovascular disease—three of the top four leading causes of death in the U.S.

Beginning in 2013, each year at the Workshop the Prevent Cancer Foundation® presents the James L. Mulshine, M.D., National Leadership Award to an individual who has had a profound impact on reducing the toll these diseases take on the health of Americans and individuals around the world.

Past recipients of this award include:

  • 2020 – Daniel C. Sullivan, M.D. for his work in founding and chairing the Quantitative Imaging Biomarkers Alliance (QIBA). QIBA is committed to transforming patient care by making radiology a more quantitative science.
  • 2019 – Andrew C. von Eschenbach, M.D., Director, National Cancer Institute, for his design, implementation and management of the largest and most expensive clinical trial in its history, the National Lung Screening Trial (NLST)
  • 2018 – Sharon Y. Eubanks, U.S. Department of Justice, for her work as the lead Justice Department prosecutor in the landmark racketeering trial against Big Tobacco, a case which defied predictions and was won by the government
  • 2017 – The late John Walsh, President and CEO of the COPD Foundation and President and Founder of the Alpha One Foundation
  • 2016 – Laurie Fenton Ambrose, President and CEO of the Lung Cancer Alliance, for her efforts to guide patient advocacy groups in successful efforts to gain coverage of lung cancer screening by the Centers for Medicare & Medicaid Services (CMS)
  • 2015 – Claudia Henschke, Ph.D., M.D., Mt. Sinai Medical Center, as a pioneer of the use of low-dose spiral CT to screen for lung cancer
  • 2014 – CVS Health, award accepted by Nancy Gagliano, M.D., CVS Chief Medical Officer, in recognition of the company’s bold decision to discontinue the sale of tobacco products in their stores
  • 2013 (Inaugural year of the Award) – Cheryl G. Healton, Ph.D., President and CEO, Legacy Foundation and Dean of the College of Public Health at New York University, in recognition of over 25 years of tireless work in public health, specifically on tobacco control

Support the Quantitative Imaging Workshop  

The Prevent Cancer Foundation® values its partnerships with its supporters and appreciates the impact we make together on increasing cancer screening and early detection. If your organization would like to support the Quantitative Imaging Workshop, or for more information on how you can become a corporate partner, please contact Becca Ginns at becca.ginns@preventcancer.org.

Special thanks to the 2021 Quantitative Imaging Workshop XVII supporters!

American Lung Association

AstraZeneca

Bristol Myers Squibb

GO2 Foundation

Helsinn

Imbio

Join now to keep up with the latest in cancer prevention and early detection